Shaanxi Meibang Pharmaceutical Group Co., Ltd.
SSE:605033.SS
16.97 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 36.859 | 57.557 | 145.088 | 125.743 | 78.734 | 76.257 | 59.33 | 61.225 |
| Depreciation & Amortization
| 21.748 | 21.217 | 15.473 | 12.478 | 0.329 | 0.43 | 0.335 | 0.351 |
| Deferred Income Tax
| 0 | 0 | -7.935 | 0.131 | 1.602 | 0.438 | 0.415 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 4.835 | 4.835 |
| Change In Working Capital
| 214.785 | 246.54 | -44.747 | -263.453 | -18.216 | 29.733 | -68.842 | -47.105 |
| Accounts Receivables
| 66.492 | 98.492 | -57.22 | -105.489 | -49.96 | 10.888 | 15.542 | -25.282 |
| Inventory
| 67.585 | 85.478 | 92.308 | -293.905 | -48.06 | 47.091 | -84.678 | -28.871 |
| Accounts Payables
| 0 | 67.443 | -71.899 | 135.81 | 49.96 | -10.888 | 0 | 0 |
| Other Working Capital
| 80.708 | -4.874 | -7.935 | 0.131 | 29.845 | -17.358 | 15.836 | -18.234 |
| Other Non Cash Items
| 7.007 | 9.475 | 10.597 | 16.479 | 14.028 | 22.029 | 26.135 | 14.934 |
| Operating Cash Flow
| 280.399 | 334.789 | 126.412 | -108.754 | 74.875 | 128.449 | 16.959 | 29.405 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -158.812 | -203.69 | -109.29 | -106.528 | -61.708 | -33.78 | -34.862 | -17.56 |
| Acquisitions Net
| 0 | 0 | 0.028 | -0 | 0.02 | 1.601 | 0 | 0.03 |
| Purchases Of Investments
| -2,298 | -1,128 | -933.1 | -499 | -654 | -302 | -96.5 | -201.8 |
| Sales Maturities Of Investments
| 1,917.759 | 1,208 | 1,005.211 | 351.909 | 669.02 | 310.918 | 155.806 | 188.637 |
| Other Investing Activites
| 1.585 | 6.511 | 2.75 | 1.703 | 3.176 | 0.357 | 0.449 | 0.489 |
| Investing Cash Flow
| -537.468 | -117.178 | -34.401 | -251.917 | -43.492 | -22.905 | 24.894 | -30.203 |
| Financing Activities: | ||||||||
| Debt Repayment
| 72 | 1 | -27.051 | 0 | -40 | 13 | -22 | 0 |
| Common Stock Issued
| 0 | 0 | 25.567 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -25.914 | -25.567 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -28.24 | -29.744 | -25.688 | -3.292 | -0.699 | -2.07 | -3.581 | -3.6 |
| Other Financing Activities
| -18.907 | -29.671 | 94.576 | 353.88 | -19 | 11 | 40.782 | 3 |
| Financing Cash Flow
| 24.853 | -58.415 | 41.837 | 350.587 | -59.699 | 21.93 | 15.201 | -0.6 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0 | 0 | 0 | 0.059 | -0.011 | -0 | 0 | -0.011 |
| Net Change In Cash
| -232.216 | 159.196 | 133.848 | -10.025 | -28.326 | 127.474 | 57.054 | -1.409 |
| Cash At End Of Period
| 220.215 | 452.431 | 293.235 | 159.388 | 169.412 | 197.739 | 70.265 | 13.211 |